Phase III Study of Canakinumab (ACZ885) As Adjuvant Therapy in Patients with Surgically Resected NSCLCM. Thomas,P. Christopoulos,E. B. Garon,A. Ardizzoni,F. Barlesi,B. C. Cho,P. De Marchi, Y. Goto,S. Lu,L. Paz-Ares Rodriguez,D. R. Spigel,A. Kay,P. C. Arratia,J. Baum, Y. Y. Lau, C. Zheng,J. C. -H. YangONCOLOGY RESEARCH AND TREATMENT（2018）引用 0|浏览18暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
